NCT04094519 2024-11-20A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate CancerAstellas Pharma IncPhase 1 Completed24 enrolled
NCT04776889 2021-03-02The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer PatientsNational Cancer Institute, EgyptPhase 4 Completed70 enrolled